Telehealth company Hims & Hers Health is set to air its first Super Bowl ad Sunday (Feb. 9), promoting compounded weight-loss drugs -- sparking allegations from a bipartisan Senate duo, the Pharmaceutical Research and Manufacturers of America (PhRMA) and a public health group that the ad is misleading and goes against the intent of FDA’s prescription drug advertising rules.